- Home
- / AVITA Medical
AVITA Medical
Stock Price
$10.3
2024-10-29
Market Capitalization
$274.5 M
2024-10-29
Revenue
$71.6 M
FY, 2025
AVITA Medical Summary
Company Summary
- Overview
- AVITA Medical (formerly AVITA Therapeutics) is a medical device company developing and distributing wound care solutions. Its core product is RECELL System, a device used for the treatment of thermal burn and trauma wounds. Also, the company holds rights to wound care solutions, such as PermeaDerm, a biosynthetic wound matrix, and Cohealyx, a collagen-based dermal matrix.
- Type
- Public
- Status
- Active
- Founded
- 1992
- HQ
- Santa Clarita, CA, US | view all locations
- Website
- https://avitamedical.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Jeremy Curnock Cook, Non-Executive Director
Suzanne Crowe, Non-Executive Director
LocationsView all
1 location detected
Santa Clarita, CA HQ
United States
28159 Avenue Stanford Suite 220, Valencia
AVITA Medical Financials
Summary Financials
- Revenue (Q1, 2026)
- $19.3M
- Gross profit (Q1, 2026)
- $15.7M
- Net income (Q1, 2026)
- ($10.6M)
- Cash (Q1, 2026)
- $8.3M
- EBIT (Q1, 2026)
- ($8.8M)
- Enterprise value
- $314.3M